Business
Paysign, Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results
Company’s Board Authorizes $5 Million Share Repurchase Program For the Full Year Full-year 2022 total revenues of $38.0 million, up 29% from full-year 2021
About this update from Paysign, Inc.
[{"type":"text","content":"\nCompany’s Board Authorizes $5 Million Share Repurchase Program\n\nFor the Full Year\n\n\nFull-year 2022 total revenues of $38.0 million, up 29% from full-year 2021\n\n\nFull-year 2022 net income of $1.0 million, or diluted earnings per share of $0.02\n\n\nFull-year 2022 Adjusted EBITDA of $5.5 million, up 175% from $2.0 million a year ago, while diluted Adjusted EBITDA per share was $0.10 versus $0.04 for full-year 2021 (Adjusted EBITDA and Adjusted EBITDA per share are non-GAAP metrics used by management to gauge the operating performance of the business – see reconciliation of Net Income to Adjusted EBITDA at the end of the press release)\n\n\nAdded 78 net plasma donation centers during 2022, exiting the year with 444 centers\n\n\nFull-year 2022 gross dollar load volume was up 40% over 2021\n\n\nFull-year 2022 gross spend volume was up 47% over 2021\n\n\nFor the Fourth Quarter\n\n\nFourth quarter total revenues of $10.6 million, up 21% from fourth quarter 2021\n\n\nFourth quarter net income of $0.7 million, or diluted earnings per share of $0.01\n\n\nFourth quarter Adjusted EBITDA of $1.7 million, up 38% from $1.3 million a year ago, while diluted Adjusted EBITDA per share was $0.03 versus $0.02 for the fourth quarter 2021 (Adjusted EBITDA and Adjusted EBITDA per share are non-GAAP metrics used by management to gauge the operating performance of the business – see reconciliation of Net Income to Adjusted EBITDA at the end of the press release)\n\n\nFourth quarter gross dollar load volume up 44.4% versus the year-ago period\n\n\nFourth quarter gross spend volume was up 51.3% versus the year-ago period\n\n\nThe Paysign Board of Directors has authorized the repurchase of up to $5.0 million of common stock\n\n\n HENDERSON, Nev.--(BUSINESS WIRE)--\nPaysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the fourth quarter and full-year 2022.\n\n“We closed out 2022 with strong financial results, and I am pleased with the opportunities that lie ahead of us for 2023,” said Mark Newcomer, Paysign CEO. “We saw continued growth in our plasma business with the addition of 91 centers in the year, leaving us with a net gain of 78 centers. We more than doubled the number of pati...